• CSL shares surge 18% as ‘reset year’ points to a return to growth

    Male Lab Worker Wearing White Coat Recording Test Results On Computer.

    CSL Ltd (ASX: CSL) shares surged 18% to $158.24 in early afternoon trade on Tuesday That’s a welcome change for shareholders after the ASX healthcare stock lost 42% over the past 12 months.

    By comparison, the S&P/ASX 200 Index (ASX: XJO) has gained around 2% over the same period.

    Investors appear encouraged by CSL’s latest full-year results and, in particular, management’s outlook following what the company describes as a ‘reset year’.

    CSL’s reset year

    For the year ended 30 June 2026, CSL reported total revenue of US$15.8 billion, down 1% year-over-year. Underlying NPATA fell 2% to US$3.1 billion.

    The headline statutory result was considerably weaker, with CSL reporting a net loss after tax of US$2.6 billion. However, this reflected significant one-off costs and impairments.

    CSL spent FY26 undertaking a broad transformation program, including about US$176 million in cost savings, the integration of its Behring and Vifor operations and US$799 million in restructuring costs.

    The company also booked US$7.1 billion of pre-tax asset impairments, largely reflecting changes to commercial outlooks, generic competition, regulatory developments and site-utilisation assumptions.

    What comes next for CSL shares?

    Importantly, management expects FY27 to mark a return towards growth. Revenue is forecast to remain broadly steady, while underlying NPAT is expected to increase by approximately 5%.

    CSL Behring is expected to deliver mid-single-digit revenue growth, supported particularly by immunoglobulin demand. CSL Seqirus is targeting low-single-digit growth, although softer US immunisation rates remain a headwind.

    Vifor, meanwhile, is expected to decline amid generic competition and regulatory changes.

    CSL is also continuing to invest for the longer term. The company announced a new US$1.1 billion share buyback and remains focused on developing new therapies and expanding its US plasma manufacturing network.

    It has also entered a strategic partnership with VarmX for a novel blood-coagulation treatment.

    What did management say?

    Interim CEO and Managing Director Gordon Naylor said:

    FY26 has been a year of reset. We have taken decisive action and created a clear path to return to sustainable growth.

    Plasma market fundamentals and demand remain robust and momentum is building behind our newer therapies, such as ANDEMBRY® and HEMGENIX.

    We have made solid progress on our transformation program and continue to simplify the business. We have also invested in our commercial capabilities and development programs to drive top line growth in the future.

    For CSL shareholders, the sharp share price rebound suggests the market is willing to look beyond FY26’s difficult numbers and focus instead on the company’s potential return to sustainable growth.

    The post CSL shares surge 18% as ‘reset year’ points to a return to growth appeared first on The Motley Fool Australia.

    Should you invest $1,000 in CSL right now?

    Before you buy CSL shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why this $1.4 billion ASX All Ords mining stock is tipped to jump 30%

    A group of five engineers wearing hard hats and some in high visibility vests raise their arms in happy celebration atop a building site with construction and equipment in the background.

    Already trading near its all-time highs, the All Ordinaries Index (ASX: XAO) is unlikely to return 30% over the coming year, but this ASX All Ords mining stock is tipped to do just that.

    That’s according to the team at wealth manager Euroz Hartleys, who recently reiterated their speculative buy rating on BCI Minerals Ltd (ASX: BCI).

    In afternoon trade today, BCI Minerals shares are trading for 46 cents apiece. That’s up 27.8% since this time last year. And it gives the ASX All Ords mining stock a market cap of around $1.35 billion.

    Looking ahead, Euroz Hartleys is bullish on the potential for BCI’s Mardie Salt Project, located in Western Australia. The project covers some 115 square kilometres on the Pilbara coast. On completion, which is nearing, it will be the third-largest salt project in the world and the largest in Australia, producing 5.35 million tonnes per annum (Mtpa).

    MCI is aiming to complete construction of the Mardie Salt Project inside the next half year. First sales are targeted for the end of the first quarter of calendar year 2027 (Q1 2027).

    Should I buy the ASX All Ords mining stock today?

    BCI announced the results of its June quarter update on 20 July.

    In a report released on 11 August, Euroz Hartleys noted, “Development is now 85% complete, with $1.19bn spent to date and the remaining $258m construction cost (+ WC) fully funded by $423m of liquidity.”

    The wealth manager added:

    Importantly, BCI has commenced salt crystallisation, with 49kt of crystallised salt on hand at 30 Jun ’26, marking a key transition from construction towards operations. BCI expects to be operationally ready for FSOS in Q1 CY27, although first harvest remains weather dependent, with adverse conditions potentially delaying timing by up to 6 months.

    Summarising their buy rating on the ASX All Ords mining stock, Euroz Hartleys’ analysts said:

    At salt-only steady-state 5.35 mtpa full run-rate (from FY30 on our numbers), BCI is forecast to generate ~$250m EBITDA p.a. with a long asset life (60+yrs) given ‘unlimited’ reserves (seawater), with low sustaining capex providing strong FCF [free cash flow] generation (~$190m p.a.) and the basis for material shareholder returns (assuming 80-100% payout).

    Tolling opportunities (i.e. nearby stranded iron ore) from the spare capacity at the 100%-owned 20mtpa Cape Preston West Port offers an additional material revenue stream (>$100m p.a. potential) and SOP (and other waste stream/salt bitterns products) provide very real medium-term upside for staged earnings growth on top of the salt (+$70m EBITDA p.a.).

    Euroz Hartleys has a price target of 60 cents per share on the ASX All Ords mining stock.

    That represents an upside of more than 30% from the current MCI Minerals share price.

    The post Why this $1.4 billion ASX All Ords mining stock is tipped to jump 30% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Bci Minerals right now?

    Before you buy Bci Minerals shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Bci Minerals wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Everything you need to know about the BHP dividend

    Flying Australian dollars, symbolising dividends.

    Owners of BHP Group Ltd (ASX: BHP) shares can celebrate because the ASX mining share has risen 3%, and the BHP dividend has been announced.

    The company revealed that revenue grew 15% to US$58.8 billion, profit from operations increased 23% to US$23.9 billion, underlying attributable profit grew 30% to US$13.2 billion, and attributable profit rose 9%.  

    Profit generation funds the payment of dividends, so the fact that the company reported significant financial progress was a very helpful sign for the company to fund larger payouts.

    Let’s look at how big the dividend payout will be.

    BHP FY26 dividend

    The ASX mining share wants to provide good passive income payments to shareholders.

    The BHP board of directors declared an FY26 final dividend of US 99 cents, representing a 65% increase compared to the final dividend from FY25. That brought the full-year dividend to US$1.72, an increase of 56%.

    These payouts mean the business is paying a total distribution of US$8.7 billion to owners of BHP shares, representing 66% of underlying attributable profit. BHP aims to provide investors with a minimum dividend payout ratio of 50% of underlying attributable profit for every reporting period.

    Investors can utilise the dividend reinvestment plan (DRP) to receive the dividend as new BHP shares rather than cash.

    When will the passive income be paid?

    I’ll get to the dividend payment date in a moment, but first investors need to know about the ex-dividend date. Investors wanting to receive the payout need to own shares before the ex-dividend date or else they’ll miss out.

    For the FY26 final dividend, BHP disclosed that the ex-dividend date is 3 September 2026, which is just over two weeks. That means investors need to own BHP shares by the end of trading on 2 September 2026 if they want to receive the upcoming payout.

    After that date, the ASX mining share will pay its FY26 final dividend per share on 23 September 2026. That means investors only need to wait just over a month until the cash can hit their bank account.

    If a shareholder wants to participate in the dividend reinvestment plan, they have until Monday, 7 September 2026 at 5pm to make that election.

    What is the BHP dividend yield?

    At the current BHP share price and exchange rate, the final dividend of US 99 cents is approximately AU$1.39. That’s a dividend yield of 2.2%, excluding franking credits, and 3.1%, including franking credits.

    The full-year dividend of US$1.72 translates into approximately A$2.42. That equates to a dividend yield of 3.8%, excluding franking credits, and 5.4%, including franking credits.

    That’s not one of the most exciting dividend yields around, so investors may want to also consider other ASX shares that could be attractive for passive dividend income.

    The post Everything you need to know about the BHP dividend appeared first on The Motley Fool Australia.

    Should you invest $1,000 in BHP Group right now?

    Before you buy BHP Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and BHP Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Top Analyst Sees the Value of These 3 Airline Stocks Differently Than Warren Buffett

  • Former Google CEO Eric Schmidt Cut Last Ties With The Company: Report

  • Waiting for coronavirus stimulus check? Direct deposit information is due Wednesday, IRS says

  • CytomX Therapeutics, Inc. Just Beat Earnings Expectations: Here’s What Analysts Think Will Happen Next